Sign in Subscribe
Class action lawsuits

LifeMD Securities Class Action Lawsuit: Important October 27 Deadline

Strategic Insights

— 1 min read

Purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025 may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed, and investors have until October 27, 2025 to join the case. Rosen Law Firm, a global investor rights law firm, reminds investors of the impending deadline.

Key Takeaways:

  • The lawsuit alleges that defendants made materially false and/or misleading statements and/or failed to disclose that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound.
  • The class action lawsuit was filed by Rosen Law Firm on behalf of investors who purchased LifeMD securities during the Class Period, which spans from May 7, 2025 to August 5, 2025.
  • To join the case, investors can go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email for information on the class action.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation, and investors must move the Court no later than October 27, 2025, to be eligible.
  • The Rosen Law Firm has a track record of success in securities class actions and shareholder derivative litigation, with notable achievements including the largest ever securities class action settlement against a Chinese Company and being ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Statistics:

  • The lawsuit spans from May 7, 2025 to August 5, 2025, with investors having from May 7, 2025 to August 5, 2025 to purchase LifeMD securities.
  • The class action lawsuit was filed by Rosen Law Firm, which represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • In 2019, Rosen Law Firm secured over $438 million for investors, and in 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar.

Sources:

  • GlobeNewswire. "WHY: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against LifeMD, Inc. - LFMD" (September 15, 2025)
  • Law Firm's website. Rosen Law Firm
  • ISS Securities Class Action Services. "2021 Class Action Report"

Read more